Piramal Pharma Ltd

BSE : PPLPHARMA17 Jan 2025
Pharmaceuticals
-3.45 (-1.47%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Piramal Pharma Ltd
Piramal Pharma Ltd
Pharmaceuticals
BSE : PPLPHARMA17 Jan 2025
-3.45 (-1.47%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All

Piramal Pharma Ltd - Share Price & Details

Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
67.33%
Upper Circuit
Lower Circuit
P/E TTM
47.58
P/B Ratio
4.36
Traded Value(Cr)
0.00
EPS TTM
4.85
Book value
Dividend
0.05%

Invest in Piramal Pharma Ltd at ZERO Brokerage for 30 days

Price Performance

4.11 %
1 Wk
-11.44 %
1 M
2.81 %
3 M
67.33 %
1 Y
-10.61 %
YTD

Traded Volume Movement

Technical Details

Support 3
224
Support 2
226
Support 1
229
Pivot Point :
232
Resistance 1
234
Resistance 2
237
Resistance 3
239

Reports

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Piramal Pharma Ltd
₹230.75(-3.45/-1.47%)
230.75-3.4530,591.6467.3347.584.36
Bliss GVS Pharma Ltd
₹161.55(+0.40/0.25%)
161.55+0.401,702.1929.0321.061.66
Amrutanjan Health Care Ltd
₹696.00(+1.20/0.17%)
696.00+1.202,012.1816.3642.346.76
Astrazeneca Pharma India Ltd
₹6,913.95(+117.85/1.73%)
6,913.95+117.8517,284.889.64134.2825.44
Abbott India Ltd
₹27,951.80(+640.70/2.35%)
27,951.80+640.7059,397.588.6246.2416.87
Ambalal Sarabhai Enterprises Ltd
₹49.82(-1.23/-2.41%)
49.82-1.23381.79-1.8143.328.47

About Piramal Pharma Ltd

Piramal Pharma Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 30591.64 crores. It has reported a sales of Rs. 1284.39 crores and a net profit of Rs. 210.06 crores for the quarter ended December 2018. The company management includes Nandini Piramal, Nandini Piramal,PETER D DEYOUNG,Neeraj Bharadwaj,Jairaj Purandare,S Rama Dorai,Peter Stevenson,Sridhar Gorthi,Vibha Paul Rishi,Vivek Valsaraj,Tanya D'Costa (Piramal Pharma Ltd) among others.
Chairman
Nandini Piramal
Registered office
Ground Floor Piramal Ananta,Agastya Corp.Park LBS MargKurl,Mumbai,Maharashtra,400070
FAX :91-22-3802 3884
Background
Incorporation Year2020
Face Value₹10
Market Lot1

Latest News

Gold Rate And Silver Price Today on January 19, 2025

Gold prices experienced a modest decrease on Sunday. The cost of 24 carat gold in India is Rs.8128.3 per gram, reflecting an decrease of  ₹ 170.0. The cost of 22 carat gold in India is 7452.3 per gram,  a fall of ₹160.0. The price fluctuation of 24 carat gold over the past week is recorded at -1.23%. The current price of silver in India is 99600.0 per kg, reflecting an decrease of 100.0 per kg.
19 Jan 2025 | 12:06 PM

Hitachi Energy to raise funds worth ₹4,200 cr via equity shares

Bengaluru-based Hitachi Energy India Limited announced plans to raise funds of an aggregate amount not exceeding ₹4,200 crore. The company’s Board of Directors approved the proposal during a meeting held on January 18, 2025. The funds may be raised through equity shares or other securities, including convertible debentures, warrants, or preference shares.
18 Jan 2025 | 04:49 PM

Famous All-Carbon Superyacht Gets $2 Million More Knocked Off Price

You might call it a golden opportunity.  Some yacht owners like to be inconspicuous. That’s not the case for the owner of the 162-foot Khalilah, whose sports yacht is painted gleaming gold, has its own matching miniature chase boat and has a unique carbon-fiber construction that ensures reduced fuel consumption and maximum efficiency.
18 Jan 2025 | 03:46 PM

Kalyan Jewellers share price

Kalyan Jewellers share price: After hitting an all-time high of  ₹795.40 apiece on the NSE, the jewellery stock has been on a continuous downtrend since then. Kalyan Jewellers’ share price ended at  ₹502.20 per share on the NSE on Friday, recording around a 37 per cent dip in the YTD. However, the jewellery brand has become worth watching ahead of the Union Budget 2025.
18 Jan 2025 | 03:36 PM

RBL Bank Q3 results: Net profit plummets 86% on-year

RBL Bank on 18 January reported an 86% year-on-year (YoY) decline in its net profit to ₹32.63 crore for the third quarter of FY25, largely attributed to higher provisions. Sequentially, net profit dropped 85%. Gross non-performing asset (NPA) ratio rose slightly to 2.92% as of 31 December 2024, compared to 2.88% in the previous quarter, but improved from 3.12% a year ago.
18 Jan 2025 | 02:04 PM

How to buy Piramal Pharma Ltd shares on nse?

To buy Piramal Pharma Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Piramal Pharma Ltd share price today?

The Piramal Pharma Ltd shares price on nse is Rs.230.75 today.

What is the market cap of Piramal Pharma Ltd shares on BSE ?

The company has a market capitalization of Rs.30591.64Cr

What is the PE & PB ratio of Piramal Pharma Ltd shares ?

PE is 47.58 and PB is 4.36

What is the 52 Week High and Low of Piramal Pharma Ltd shares?

Piramal Pharma Ltd stock price high: Rs.307.85 Piramal Pharma Ltd stock price low: Rs.114.45

What can be the future price of Piramal Pharma shares on BSE?

The current price of Piramal Pharma on BSE is 71.51 (24 March 2023, 3:25 PM).

The future price of any shares on BSE, including those of Piramal shares are based on a variety of factors and these may lead to changes in the price of a stock at any time. The following factors must be considered while thinking of the future price of Piramal Pharma stocks: 

  • The position of the company in the pharmaceutical industry
  • Innovations of the company
  • Financial and overall company performance
  • Macroeconomic factors
  • Demand for pharmaceuticals
  • Competition

Is it safe to buy Piramal Pharma?

Piramal Pharma, a pharmaceutical company and part of the erstwhile Piramal Group, is a global business with a focus on providing innovative/integrated solutions across the total drug development and manufacturing value chain, right from drug discovery to the commercialisation of medicines. 

Whether a stock is safe to buy or not should be based on many factors like the financials of the company, the competition, the position of the company in the industry, macroeconomic factors and more. 

Nonetheless, the net sales of Piramal Pharma were at Rs. 6559 crores in March 2022, and the net profit was at Rs. 376 crores.

 

What is the current market value per shares of Piramal Pharma?

The current price of Piramal Pharma on BSE is 71.51 (24 April 2023, 3:25 PM).

Does Piramal Pharma have any debts?

As of 24 April 2023, Piramal Pharma has debt amounting to Rs. 5016 crores. 

Will Piramal Pharma shares price increase?

The ROI on Piramal Pharma stock is -65.32% (YTD). 

Determining whether share prices will increase depends on many factors like macroeconomic factors, the company’s performance, trends in the industry, the competition and other variables that influence stock prices frequently, besides on a long-term basis.

 

Should I buy or sell Piramal Pharma?

The 3-month returns on investment (ROI) of Piramal Pharma stock is -35.62%, and YTD is at -65.32%. 

Given this data, any stock’s movement depends on several factors which include: 

  • Company performance
  • Industry trends
  • Market trends
  • Competition
  • Demand and supply
  • Macroeconomic trends
Click here to see your activities